108 related articles for article (PubMed ID: 34678588)
1. Small peptide targeting ANP32A as a novel strategy for acute myeloid leukemia therapy.
Wang M; Guo H; Zhang X; Wang X; Tao H; Zhang T; Peng M; Zhang M; Huang Z
Transl Oncol; 2022 Jan; 15(1):101245. PubMed ID: 34678588
[TBL] [Abstract][Full Text] [Related]
2. ANP32A regulates histone H3 acetylation and promotes leukemogenesis.
Yang X; Lu B; Sun X; Han C; Fu C; Xu K; Wang M; Li D; Chen Z; Opal P; Wen Q; Crispino JD; Wang QF; Huang Z
Leukemia; 2018 Jul; 32(7):1587-1597. PubMed ID: 29467488
[TBL] [Abstract][Full Text] [Related]
3. Acidic leucine-rich nuclear phosphoprotein-32A expression contributes to adverse outcome in acute myeloid leukemia.
Huang S; Huang Z; Ma C; Luo L; Li YF; Wu YL; Ren Y; Feng C
Ann Transl Med; 2020 Mar; 8(6):345. PubMed ID: 32355789
[TBL] [Abstract][Full Text] [Related]
4. AIMP1 promotes multiple myeloma malignancy through interacting with ANP32A to mediate histone H3 acetylation.
Wei R; Zhu Y; Zhang Y; Zhao W; Yu X; Wang L; Gu C; Gu X; Yang Y
Cancer Commun (Lond); 2022 Nov; 42(11):1185-1206. PubMed ID: 36042007
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Histone Acetylation by ANP32A Induces Memory Deficits.
Chai GS; Feng Q; Ma RH; Qian XH; Luo DJ; Wang ZH; Hu Y; Sun DS; Zhang JF; Li X; Li XG; Ke D; Wang JZ; Yang XF; Liu GP
J Alzheimers Dis; 2018; 63(4):1537-1546. PubMed ID: 29782322
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of LIN28B impairs leukemia cell growth and metabolism in acute myeloid leukemia.
Zhou J; Bi C; Ching YQ; Chooi JY; Lu X; Quah JY; Toh SH; Chan ZL; Tan TZ; Chong PS; Chng WJ
J Hematol Oncol; 2017 Jul; 10(1):138. PubMed ID: 28693523
[TBL] [Abstract][Full Text] [Related]
7. Downregulating ANP32A rescues synapse and memory loss via chromatin remodeling in Alzheimer model.
Chai GS; Feng Q; Wang ZH; Hu Y; Sun DS; Li XG; Ke D; Li HL; Liu GP; Wang JZ
Mol Neurodegener; 2017 May; 12(1):34. PubMed ID: 28472990
[TBL] [Abstract][Full Text] [Related]
8. A novel miR-375-HOXB3-CDCA3/DNMT3B regulatory circuitry contributes to leukemogenesis in acute myeloid leukemia.
Bi L; Zhou B; Li H; He L; Wang C; Wang Z; Zhu L; Chen M; Gao S
BMC Cancer; 2018 Feb; 18(1):182. PubMed ID: 29439669
[TBL] [Abstract][Full Text] [Related]
9. Histone Acetyltransferase p300/CREB-binding Protein-associated Factor (PCAF) Is Required for All-
Sunami Y; Araki M; Kan S; Ito A; Hironaka Y; Imai M; Morishita S; Ohsaka A; Komatsu N
J Biol Chem; 2017 Feb; 292(7):2815-2829. PubMed ID: 28053092
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic potential of GSK-J4, a histone demethylase KDM6B/JMJD3 inhibitor, for acute myeloid leukemia.
Li Y; Zhang M; Sheng M; Zhang P; Chen Z; Xing W; Bai J; Cheng T; Yang FC; Zhou Y
J Cancer Res Clin Oncol; 2018 Jun; 144(6):1065-1077. PubMed ID: 29594337
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-21 targets tumor suppressor genes ANP32A and SMARCA4.
Schramedei K; Mörbt N; Pfeifer G; Läuter J; Rosolowski M; Tomm JM; von Bergen M; Horn F; Brocke-Heidrich K
Oncogene; 2011 Jun; 30(26):2975-85. PubMed ID: 21317927
[TBL] [Abstract][Full Text] [Related]
12. Targeting AML1/ETO-histone deacetylase repressor complex: a novel mechanism for valproic acid-mediated gene expression and cellular differentiation in AML1/ETO-positive acute myeloid leukemia cells.
Liu S; Klisovic RB; Vukosavljevic T; Yu J; Paschka P; Huynh L; Pang J; Neviani P; Liu Z; Blum W; Chan KK; Perrotti D; Marcucci G
J Pharmacol Exp Ther; 2007 Jun; 321(3):953-60. PubMed ID: 17389244
[TBL] [Abstract][Full Text] [Related]
13. A histone acetyltransferase p300 inhibitor C646 induces cell cycle arrest and apoptosis selectively in AML1-ETO-positive AML cells.
Gao XN; Lin J; Ning QY; Gao L; Yao YS; Zhou JH; Li YH; Wang LL; Yu L
PLoS One; 2013; 8(2):e55481. PubMed ID: 23390536
[TBL] [Abstract][Full Text] [Related]
14. ANP32A promotes the proliferation, migration and invasion of hepatocellular carcinoma by modulating the HMGA1/STAT3 pathway.
Tian Z; Liu Z; Fang X; Cao K; Zhang B; Wu R; Wen X; Wen Q; Shi H; Wang R
Carcinogenesis; 2021 Apr; 42(3):493-506. PubMed ID: 33332531
[TBL] [Abstract][Full Text] [Related]
15. Novel Polyethylene Glycol-Conjugated Triazole Derivative with High Thyrointegrin αvβ3 Affinity in Acute Myeloid Leukemia Management.
Sudha T; Godugu K; Darwish NHE; Nazeer T; Mousa SA
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439224
[TBL] [Abstract][Full Text] [Related]
16. Emodin and Its Combination with Cytarabine Induce Apoptosis in Resistant Acute Myeloid Leukemia Cells in Vitro and in Vivo.
Chen Y; Gan D; Huang Q; Luo X; Lin D; Hu J
Cell Physiol Biochem; 2018; 48(5):2061-2073. PubMed ID: 30099447
[TBL] [Abstract][Full Text] [Related]
17. Quantitative proteomic analysis of histone modifications in decitabine sensitive and resistant leukemia cell lines.
Zhang C; Suo J; Katayama H; Wei Y; Garcia-Manero G; Hanash S
Clin Proteomics; 2016; 13():14. PubMed ID: 27382363
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of 1,2-benzisoxazole tethered 1,2,3-triazoles that exhibit anticancer activity in acute myeloid leukemia cell lines by inhibiting histone deacetylases, and inducing p21 and tubulin acetylation.
Ashwini N; Garg M; Mohan CD; Fuchs JE; Rangappa S; Anusha S; Swaroop TR; Rakesh KS; Kanojia D; Madan V; Bender A; Koeffler HP; Basappa ; Rangappa KS
Bioorg Med Chem; 2015 Sep; 23(18):6157-65. PubMed ID: 26299825
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of poly(ADP-ribose) polymerase 1 protects against acute myeloid leukemia by suppressing the myeloproliferative leukemia virus oncogene.
Wang L; Cai W; Zhang W; Chen X; Dong W; Tang D; Zhang Y; Ji C; Zhang M
Oncotarget; 2015 Sep; 6(29):27490-504. PubMed ID: 26314963
[TBL] [Abstract][Full Text] [Related]
20. Butyrates, as a single drug, induce histone acetylation and granulocytic maturation: possible selectivity on core binding factor-acute myeloid leukemia blasts.
Gozzini A; Rovida E; Dello Sbarba P; Galimberti S; Santini V
Cancer Res; 2003 Dec; 63(24):8955-61. PubMed ID: 14695213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]